Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Dermira Inc. (DERM)

18.75   0 (0%) 02-19 16:00
Open: 18.75 Pre. Close: 18.75
High: 18.77 Low: 18.74
Volume: 1,072,156 Market Cap: 1026M
Dermira Inc is a biopharmaceutical company. It is engaged in identifying, developing and commercializing therapies to improve the lives of patients with dermatologic diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.772 - 18.871 18.871 - 18.955
Low: 18.51 - 18.625 18.625 - 18.722
Close: 18.563 - 18.756 18.756 - 18.921

Technical analysis

as of: 2020-02-28 4:27:44 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 22.22     One year: 22.47
Support: Support1: 18.68    Support2: 15.54
Resistance: Resistance1: 19.03    Resistance2: 19.24
Pivot: 18.78
Moving Average: MA(5): 18.74     MA(20): 18.77
MA(100): 11.90     MA(250): 10.58
MACD: MACD(12,26): 0.54     Signal(9): 0.76
Stochastic oscillator: %K(14,3): 13.58     %D(3): 15.31
RSI: RSI(14): 71.88
52-week: High: 19.48  Low: 5.25  Change(%): 134.1
Average Vol(K): 3-Month: 237007  10-Days: 57071

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DERM has closed above bottom band by 36.2%. Bollinger Bands are 93.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to DERM's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sun, 23 Feb 2020 12:07:00 +0000
Better Buy: GlaxoSmithKline vs. Eli Lilly

Thu, 13 Feb 2020 12:00:00 +0000
Will Eczema Drug Dupixent Transform Sanofi?

Thu, 30 Jan 2020 18:00:00 +0000
How Eli Lilly Wowed With Its Q4 Earnings Results

Thu, 23 Jan 2020 12:00:00 +0000
What Company Will Eli Lilly Buy Next?

Wed, 22 Jan 2020 20:20:18 +0000
Notable Wednesday Option Activity: MRCY, TNDM, DERM

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 54.70
Shares Float (M) 43.14
% Held by Insiders 0.95
% Held by Institutions 94.75
Shares Short (K) 6800
Shares Short P. Month (K)

Stock Financials

EPS -4.370
Book Value (p.s.) 0.270
PEG Ratio -0.04
Profit Margin -256.08
Operating Margin -245.92
Return on Assets (ttm) -30.1
Return on Equity (ttm) -621.2
Qtrly Rev. Growth 1508.5
Gross Profit (p.s.) 0.073
Sales Per Share
EBITDA (p.s.) -3.715
Qtrly Earnings Growth
Operating Cash Flow (M) -215.17
Levered Free Cash Flow (M) -192.20

Stock Valuations

P/E -4.29
P/E Growth Ratio
P/BV 69.44
P/S 10.96
P/CF -4.77

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.